Welcome to AANS24 Program and Introduction of Richard C. Scheider Lecture

Disclosure(s):

Michael P. Steinmetz, MD: cerapedics: Speaker/Honoraria (Terminated, August 1, 2023); Globus Medical: Royalty Recipient (Ongoing), Speaker/Honoraria (Ongoing); Premia Spine: Speaker/Honoraria (Terminated, August 1, 2023)

Adam S. Arthur, MD, MPH: Arsenal Medical: Consultant (Ongoing); Azimuth: Stock Shareholder (excluding mutual funds) (Ongoing); Balt: Consultant (Ongoing), Grant/Research Support (Ongoing); Bendit: Stock Shareholder (excluding mutual funds) (Ongoing); Cerebrotech: Stock Shareholder (excluding mutual funds) (Ongoing); Cerenovus: Grant/Research Support (Ongoing); Endostream: Stock Shareholder (excluding mutual funds) (Ongoing); Johnson & Johnson: Consultant (Ongoing); Magneto: Stock Shareholder (excluding mutual funds) (Ongoing); Medtronic: Consultant (Ongoing), Grant/Research Support (Ongoing); Mentice: Stock Shareholder (excluding mutual funds) (Ongoing); Microvention: Consultant (Ongoing), Grant/Research Support (Ongoing); Neuros Medical: Stock Shareholder (excluding mutual funds) (Ongoing); Penumbra: Consultant (Ongoing), Grant/Research Support (Ongoing); Perfuze: Consultant (Ongoing), Stock Shareholder (excluding mutual funds) (Ongoing); RevBio: Stock Shareholder (excluding mutual funds) (Ongoing); Scientia: Consultant (Ongoing), Stock Shareholder (excluding mutual funds) (Ongoing); Serenity: Stock Shareholder (excluding mutual funds) (Ongoing); Siemens: Consultant (Ongoing), Grant/Research Support (Ongoing); Stryker: Consultant (Ongoing); Synchron: Stock Shareholder (excluding mutual funds) (Ongoing); Tulavi Therapeutics, Inc.: Stock Shareholder (excluding mutual funds) (Ongoing); Vastrax: Stock Shareholder (excluding mutual funds) (Ongoing); VizAi: Stock Shareholder (excluding mutual funds) (Ongoing)